Blacks with Liver Cancer More Likely to Die

	Tweet

Black people with early stage liver cancer were more likely than white patients to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center.

Five years after diagnosis, 18 percent of white liver cancer patients were alive but only 15 percent of Hispanic patients and 12 percent of black patients were. Median survival times ranged from 10 months for whites and Hispanics to 8 months for blacks.

The researchers also found racial and ethnic disparities in how often patients received treatment, with black and Hispanic patients less likely than whites to have any kind of treatment. 

When researchers looked at survival only among patients who had been treated, the disparity in survival persisted, but the gap narrowed, especially for Hispanics. Blacks who had surgery lived a median 29 months, Hispanics 40 months and whites 43 months. Median survival for all races was only four to six months without treatment.

“Just under a third of the patients we looked at received treatment, which is a significant underuse of appropriate interventions for the most treatable stages of liver cancer,” says study author Christopher J. Sonnenday, M.D., M.H.S., assistant professor of surgery at the U-M Medical School and assistant professor of health management and policy at the U-M School of Public Health.

Researchers looked at data from 13,244 patients with early stage hepatocellular carcinoma, or liver cancer. Patients were identified through the Surveillance and Epidemiology End Results registry, a database from the National Cancer Institute that collects information on cancer incidence, prevalence and survival.

Results of the study appear in the December issue of Archives of Surgery.

Liver cancer incidence is increasing, and the disease is difficult to treat in its later stages. Patients diagnosed with advanced disease have only a 5 percent chance of living five years after diagnosis. Early stage disease is more treatable, with options including tumor ablation, surgery to remove a portion of the liver or liver transplant surgery.

“Liver cancer requires highly complex care that is available only in larger referral hospitals. Our study suggests that not only do members of different racial and ethnic groups face barriers to accessing this care, but the survival of blacks and Hispanics even after receiving these treatments appears to be inferior to whites,” Sonnenday says.

Liver cancer statistics: About 24,000 Americans will be diagnosed with liver cancer this year and 18,900 will die from the disease, according to the American Cancer Society

Additional authors: U-M Department of Surgery House Officers Amit K. Mathur, M.D., M.S.; Nicholas H. Osborne, M.D.; Raymond J. Lynch, M.D., M.S.; and Amir A. Ghaferi, M.D.; and Justin Dimick, M.D., M.P.H., assistant professor of surgery

Funding: National Institutes of Health

Disclosure: None

Reference: Archives of Surgery, Vol. 145, No. 12, pp. 1158-1163, Dec. 20, 2010

Resources:
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, http://www.mcancer.org
Clinical trials at U-M, http://www.UMClinicalStudies.org

###

Source: University of Michigan Health System

RELATED STORIES:
Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer   Proton beams control liver tumors   Statins may cut liver cancer risk in diabetics   New Technique in Treating Patients With Liver Cancer Proves Effective   Omega-3 fatty acids inhibit the growth of liver cancer cells   Experts find rogue stem cells in liver cancer   Liver cancer is likely caused by cycles of liver cell death and renewal   Metformin May Protect Against Liver Cancer   Combination Therapy Improves Survival Time For Patients With Advanced Liver Cancer   A diagnostic marker in hepatocellular carcinoma   Cycles of Cell Death, Proliferation Key to Liver Cancer   More evidence coffee may cut risk of liver cancer   Scientists identify specific markers that trigger aggressiveness of liver cancer   Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation   Liver transplant recipients almost 3 times more likely to develop cancer   Liver cancer patients less likely to die on wait list than candidates without carcinomas   Hepatitis C ups liver cancer risk, study confirms   Eating mandarins reduces the risk of liver disease, hardened arteries and insulin resistance   New study confirms link between nonalcoholic steatohepatitis and liver cancer   Saffron shows promise in preventing liver cancer   Personalized treatment may help some liver cancer patients   Liver Tumors Associated with Metabolic Syndrome Differ from Other Tumors

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]